Last kr243.30 DKK
Change Today -1.00 / -0.41%
Volume 1.8M
NOVOB On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
New York
Frankfurt
Frankfurt
As of 11:03 AM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lars Rebien Sørensen

Chief Executive Officer and Member of the Senior Management Board, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 63 board members in 3 different organizations across 10 different industries.

See Board Relationships
59kr14,400,000
As of Fiscal Year 2012

Background*

Mr. Lars Rebien Sørensen serves as the Chief Executive Officer and President at Danmarks Nationalbank. Mr. Sorensen has been the Chief Executive Officer at Novo Nordisk A/S since November 2000. He serves as an Equity Analyst at Handelsbanken Capital Markets, Research Division. Over the years, he has been stationed in several countries, including the Middle East and the United States. Mr. Sorensen served as Chief Executive Officer and President at Novo Nordisk Inc. He ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Chief Executive Officer, President and Director
1996-2010
Former Director
2001-2006
Former Director and Member of Audit Committee
2007-N/A
Former Director
2007-2012
Former Director
2011-Present
Director and Member of Audit Committee

Education*

Bachelor's Degree 1983
Copenhagen Business School
MA 1981
Den Kgl. Veterinær- og Landbohøjskole

Other Affiliations*

Annual Compensation*

Salarykr8,400,000
Bonuskr2,900,000
Total Annual Compensationkr11,300,000

Stock Options*

All Other Compensationkr3,100,000

Total Compensation*

Total Annual Cash Compensationkr14,400,000
Total Short Term Compensationkr11,300,000
Other Long Term Compensationkr3,100,000
Total Calculated Compensationkr14,400,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr243.30 DKK -1.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.3M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.